文献速递乳腺癌放疗放疗物理与技术

质子束治疗早期乳腺癌:临床结局的系统综述与荟萃分析

Proton Beam Therapy for Early Breast Cancer: A Systematic Review and Meta-analysis of Clinical Outcomes.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2023-03-02

该系统综述纳入2000至2022年发表的32项研究共1452例早期乳腺癌患者,评估辅助质子束治疗的临床结局。无随机试验比较质子束与光子放疗;扫描质子束治疗的不良事件严重程度低于散射质子束,扫描质子束后严重不良事件以皮炎最常见,发生率为5.7%(95%CI 4.2-7.6)。

要点

  • 32项研究共1452例早期乳腺癌患者接受辅助质子束治疗,随访中位时间2至59个月。
  • 无已发表的随机试验比较质子束治疗与光子放疗。
  • 扫描质子束治疗的不良事件严重程度低于散射质子束,且随临床靶区不同而异。

核心结论

  • 本文是对所有已发表的早期乳腺癌辅助质子束治疗临床结局的定量汇总。
  • 正在进行的随机试验将提供与标准光子放疗相比的长期安全性信息。

研究设计与样本

  • 系统综述纳入2000至2022年发表的辅助质子束治疗早期乳腺癌临床结局研究。
  • 早期乳腺癌定义为所有检测到的侵袭性癌细胞位于乳腺或附近淋巴结且可手术切除。
  • 共32项研究1452例患者报告辅助质子束治疗后的临床结局,随访中位时间2至59个月。

主要发现

  • 7项研究258例患者自2003至2015年开始接受散射质子束治疗,22项研究1041例患者自2000至2019年开始接受扫描质子束治疗。
  • 2项研究123例患者自2011年开始使用两种质子束类型,1项研究30例患者质子束类型未指明。
  • 部分乳腺质子束治疗报告498例不良事件(8项研究,358例患者),扫描质子束后无事件被归类为严重。
  • 全乳腺或胸壁±区域淋巴结质子束治疗报告1344例不良事件(19项研究,933例患者),扫描质子束后4%(44/1026)的事件为严重。
  • 扫描质子束后最常见的严重结局为皮炎,发生于5.7%(95%CI 4.2-7.6)的患者;其他严重不良结局包括感染、疼痛和肺炎(各≤1%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 无已发表的随机试验比较质子束治疗与光子放疗。
  • 正在进行的随机试验将提供与标准光子放疗相比的长期安全性信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Adjuvant proton beam therapy (PBT) is increasingly available to patients with breast cancer. It achieves better planned dose distributions than standard photon radiation therapy and therefore may reduce the risks. However, clinical evidence is lacking. METHODS AND MATERIALS: A systematic review of clinical outcomes from studies of adjuvant PBT for early breast cancer published in 2000 to 2022 was undertaken. Early breast cancer was defined as when all detected invasive cancer cells are in the breast or nearby lymph nodes and can be removed surgically. Adverse outcomes were summarized quantitatively, and the prevalence of the most common ones were estimated using meta-analysis. RESULTS: Thirty-two studies (1452 patients) reported clinical outcomes after adjuvant PBT for early breast cancer. Median follow-up ranged from 2 to 59 months. There were no published randomized trials comparing PBT with photon radiation therapy. Scattering PBT was delivered in 7 studies (258 patients) starting 2003 to 2015 and scanning PBT in 22 studies (1041 patients) starting 2000 to 2019. Two studies (123 patients) starting 2011 used both PBT types. For 1 study (30 patients), PBT type was unspecified. Adverse events were less severe after scanning than after scattering PBT. They also varied by clinical target. For partial breast PBT, 498 adverse events were reported (8 studies, 358 patients). None were categorized as severe after scanning PBT. For whole breast or chest wall ± regional lymph nodes PBT, 1344 adverse events were reported (19 studies, 933 patients). After scanning PBT, 4% (44/1026) of events were severe. The most prevalent severe outcome after scanning PBT was dermatitis, which occurred in 5.7% (95% confidence interval, 4.2-7.6) of patients. Other severe adverse outcomes included infection, pain, and pneumonitis (each ≤1%). Of the 141 reconstruction events reported (13 studies, 459 patients), the most prevalent after scanning PBT was prosthetic implant removal (34/181, 19%). CONCLUSIONS: This is a quantitative summary of all published clinical outcomes after adjuvant PBT for early breast cancer. Ongoing randomized trials will provide information on its longer-term safety compared with standard photon radiation therapy.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Holt F, Probert J, Darby SC, et al. Proton Beam Therapy for Early Breast Cancer: A Systematic Review and Meta-analysis of Clinical Outcomes. Int J Radiat Oncol Biol Phys. 2023. PMID: 36868521. doi:10.1016/j.ijrobp.2023.02.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。